Citation Impact
Citing Papers
AACVPR/ACC/AHA 2007 Performance Measures on Cardiac Rehabilitation for Referral to and Delivery of Cardiac Rehabilitation/Secondary Prevention Services
2007
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex
2018 StandoutScienceNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
High Prevalence and Associated Risk Factors for Impaired Renal Function and Urinary Abnormalities in a Rural Adult Population from Southern China
2012
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Resistant Hypertension Revisited: A Comparison of Two University-Based Cohorts
2005
Associations of Diabetes Mellitus With Total Life Expectancy and Life Expectancy With and Without Cardiovascular Disease
2007
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension
2008
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Telmisartan
2001
Healthy Lifestyle Characteristics Among Adults in the United States, 2000
2005
The metabolic syndrome: is this diagnosis necessary?1,2
2006
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
The metabolic syndrome
2010 Standout
The impact of serum uric acid on cardiovascular outcomes in the LIFE study
2004
Normalization for body size and population-attributable risk of left ventricular hypertrophyThe Strong Heart Study
2005
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Uric Acid and Cardiovascular Risk
2008 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries
2013 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Risk scoring in the assessment of cardiovascular risk
2006
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
2006 Standout
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis
2013
The metabolic syndrome
2005 Standout
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
2010 Standout
Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review
2006
Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review
2004
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Midlife Body Mass Index and Hospitalization and Mortality in Older Age
2006
Chronic kidney disease: global dimension and perspectives
2013 Standout
Worldwide access to treatment for end-stage kidney disease: a systematic review
2015 Standout
Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis
2017
Sarcopenia
2019 Standout
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled
2004
Alzheimer's Disease
2010 Standout
Global burden of blood-pressure-related disease, 2001
2008 Standout
Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy
2012 Standout
Transition‐Metal‐Catalyzed Direct Arylation of (Hetero)Arenes by CH Bond Cleavage
2009 Standout
Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis
2012
Effects of Physical Activity on Life Expectancy With Cardiovascular Disease
2005
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Chronic Kidney Disease
2016 Standout
Physician Competencies for Prescribing Lifestyle Medicine
2010 Standout
Arterial Stiffness and Cardiovascular Events
2010 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Global Disparities of Hypertension Prevalence and Control
2016 Standout
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials
2008
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Effects of Different Blood Pressure–Lowering Regimens on Major Cardiovascular Events in Individuals With and Without Diabetes Mellitus
2005
General Cardiovascular Risk Profile for Use in Primary Care
2008 Standout
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of S Oparil being referenced
Comparison of Telmisartan with Lisinopril in Patients with Mild-to-Moderate Hypertension
1999
Hypertension in women
2000
THE SEVENTH REPORT OF THE JOINT NATIONAL COMMITTEE ON PREVENTION, DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD PRESSURE. THE JNC 7 REPORT
2003 Standout
CARDIOVASCULAR COMPLICATIONS IN RELATION TO THE FRAMINGHAM RISK SCORE AND AGE IN HYPERTENSIVE PATIENTS WITH LVH
2000